YU254573A - Process for preparing new prostanoic acid derivatives - Google Patents

Process for preparing new prostanoic acid derivatives

Info

Publication number
YU254573A
YU254573A YU02545/73A YU254573A YU254573A YU 254573 A YU254573 A YU 254573A YU 02545/73 A YU02545/73 A YU 02545/73A YU 254573 A YU254573 A YU 254573A YU 254573 A YU254573 A YU 254573A
Authority
YU
Yugoslavia
Prior art keywords
acid derivatives
prostanoic acid
preparing new
new prostanoic
preparing
Prior art date
Application number
YU02545/73A
Other languages
English (en)
Inventor
J Bowler
E D Brown
K B Mallion
P R Marsham
D N Richardson
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of YU254573A publication Critical patent/YU254573A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Furan Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
YU02545/73A 1972-09-27 1973-09-26 Process for preparing new prostanoic acid derivatives YU254573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4465272A GB1428137A (en) 1972-09-27 1972-09-27 Prostanoic acid derivatives

Publications (1)

Publication Number Publication Date
YU254573A true YU254573A (en) 1982-02-28

Family

ID=10434217

Family Applications (2)

Application Number Title Priority Date Filing Date
YU02545/73A YU254573A (en) 1972-09-27 1973-09-26 Process for preparing new prostanoic acid derivatives
YU02685/80A YU268580A (en) 1972-09-27 1980-10-20 Process for preparing new prostanoic acid derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU02685/80A YU268580A (en) 1972-09-27 1980-10-20 Process for preparing new prostanoic acid derivatives

Country Status (25)

Country Link
US (1) US3931206A (nl)
JP (1) JPS49100071A (nl)
AR (1) AR207550A1 (nl)
AT (1) AT340610B (nl)
BE (1) BE805358A (nl)
CA (1) CA1037033A (nl)
CH (3) CH597175A5 (nl)
CS (3) CS178893B2 (nl)
DD (1) DD107899A5 (nl)
DE (1) DE2348632A1 (nl)
EG (1) EG11278A (nl)
ES (5) ES419143A1 (nl)
FR (1) FR2200014B1 (nl)
GB (1) GB1428137A (nl)
HU (1) HU171777B (nl)
IE (1) IE38241B1 (nl)
IL (1) IL43248A (nl)
NL (1) NL7313322A (nl)
NO (1) NO145380C (nl)
PL (2) PL96782B1 (nl)
SE (3) SE424859B (nl)
SU (1) SU648088A3 (nl)
YU (2) YU254573A (nl)
ZA (1) ZA737357B (nl)
ZM (1) ZM15873A1 (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953502A (en) 1973-01-31 1976-04-27 Imperial Chemical Industries Limited Cyclopentane derivatives
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
GB1507211A (en) * 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues
DE2524955C3 (de) 1975-06-05 1981-12-03 Hoechst Ag, 6000 Frankfurt Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung
US4464532A (en) * 1979-07-31 1984-08-07 Nippon Kayaku Kabushiki Kaisha Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
US5545665A (en) 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US6110903A (en) * 1997-03-07 2000-08-29 Sankyo Company Ltd. Benzimidazole inhibitors of fructose 1,6-bisphosphatase
AU6691798A (en) * 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
US6284748B1 (en) * 1997-03-07 2001-09-04 Metabasis Therapeutics, Inc. Purine inhibitors of fructose 1,6-bisphosphatase
AU761267C (en) * 1998-09-09 2007-08-09 Metabasis Therapeutics, Inc. Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
NZ513825A (en) * 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
JP2003519154A (ja) * 1999-12-22 2003-06-17 メタバシス・セラピューティクス・インコーポレイテッド 新規なビスアミダートホスホネートプロドラッグ
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
CN101005847A (zh) * 2004-08-18 2007-07-25 症变治疗公司 果糖1,6-双磷酸酶的新颖噻唑类抑制剂
CN113912539B (zh) * 2021-12-13 2022-03-11 山东国邦药业有限公司 一种环丙羧酸的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836578A (en) * 1965-12-16 1974-09-17 Kemiska Inst Prostanoic acid derivatives
US3726909A (en) * 1970-10-16 1973-04-10 P Beal 9,15-dihydroxy prostanoic acids and esters thereof

Also Published As

Publication number Publication date
ES444047A1 (es) 1977-04-16
IE38241B1 (en) 1978-02-01
AR207550A1 (es) 1976-10-15
ZA737357B (en) 1974-08-28
ES444045A1 (es) 1977-04-16
CS178893B2 (en) 1977-10-31
FR2200014A1 (nl) 1974-04-19
SE7611315L (sv) 1976-10-12
CS178895B2 (en) 1977-10-31
HU171777B (hu) 1978-03-28
YU268580A (en) 1983-01-21
PL96782B1 (pl) 1978-01-31
ZM15873A1 (en) 1975-05-21
DE2348632A1 (de) 1974-04-11
IL43248A (en) 1977-08-31
SE7611316L (sv) 1976-10-12
FR2200014B1 (nl) 1978-01-13
AT340610B (de) 1977-12-27
CH597175A5 (nl) 1978-03-31
NO145380B (no) 1981-11-30
EG11278A (en) 1977-08-15
DD107899A5 (nl) 1974-08-20
CS178894B2 (en) 1977-10-31
ES419143A1 (es) 1976-06-16
PL97363B1 (pl) 1978-02-28
SU648088A3 (ru) 1979-02-15
ES444046A1 (es) 1977-04-16
BE805358A (fr) 1974-03-26
CH596164A5 (nl) 1978-02-28
NL7313322A (nl) 1974-03-29
IL43248A0 (en) 1973-11-28
GB1428137A (en) 1976-03-17
ATA832673A (de) 1977-04-15
US3931206A (en) 1976-01-06
IE38241L (en) 1975-03-12
NO145380C (no) 1982-03-10
ES444044A1 (es) 1977-04-16
CA1037033A (en) 1978-08-22
JPS49100071A (nl) 1974-09-20
SE424859B (sv) 1982-08-16
CH595341A5 (nl) 1978-02-15

Similar Documents

Publication Publication Date Title
YU73575A (en) Process for preparing 16-oxygenated prostanoic acid derivatives
CS183689B2 (en) Process for preparing pyridylphenoxyalkane derivatives
HU173540B (hu) Sposob poluchenija novykh proizvodnykh 5-oksa-prostaglandina
EG11278A (en) Process for preparing prostanoic acid derivatives
YU125072A (en) Process for preparing prostanic acid derivatives
HU172472B (hu) Sposob poluchenija proizvodnykh 7-acil-amido-3-cefem-4-karbonovoj kisloty
YU228873A (en) Process for preparing novel benzoyl-benzofuran derivatives
YU179173A (en) Process for preparing 7-amino-3-cephem-4-carboxylic acid compounds
CS191903B2 (en) Process for preparing new derivatives of triiodinated aminobenzocarboxylic acid
YU126473A (en) Process for preparing new derivatives of p-dihydroxy-benzene disulfonic acid
YU100573A (en) Process for preparing novel benzo(b)tienylacetic acid derivatives
YU35897B (en) Process for preparing pregnanic acid derivatives
HU167527B (en) Process for producing 7-isocyanato-3-methyl-3-cefem-4-carboxylic acid derivatives
IL43603A0 (en) Process for preparing trans-chrysanthemic acid
YU35451B (en) Process for obtaining pregnanic acid derivatives
YU179579A (en) Process for preparing indole-carboxylic acid derivatives
CH610900A5 (en) Process for preparing novelaminopyrazoloisoquinoline derivatives
HU171818B (hu) Sposob poluchenija slozhnykh p-difenil-ehfirnykh proizvodnykh omega-arili oksa-prostaglandina
HU172016B (hu) Sposob poluchenija proizvodnykh skobka-7-zamehhennykh-skobka zakryta-fenilglicinamido-3-zamehhennykh-3-cefem-4-karbonovykh kislot
YU222474A (en) Process for preparing new pyrrazole-4-acetic acid derivatives
CH613977A5 (en) Process for preparing tricyclohexyl-tin derivatives
EG10982A (en) Process for preparing acetylamino derivatives of 2,4,6 triiodo-benzoic acid
YU35253B (en) Process for preparing 2-imidazolidione derivatives
HU173821B (hu) Sposob poluchenija novykh proizvodnykh 2 - gidroksi - 3 - amino - propana
CS187395B2 (en) Process for preparing new derivatives of benzimidazol-2-carbamic acid